open_access_logo.gif
EMBO Molecular Medicine
Wiley (2009-)
ISSN: 1757-4676 (1757-4684)
Medicine, Research & Experimental - Molecular Medicine - molecular medicine, cell biology, translational medicine

APC Discount

According to the Directory of Open Access Journals, this journal charges Article Processing Charges, please go to the  Journal Home Page to find out more
For this journal no deals have been made concerning APC discounts.More information on Open Access publishing

Metrics

JCR Science Citation Index (2021)

Impact factor: 14.005
Q1 (Medicine, Research & Experimental (9/139))

Scopus Journal Metrics (2021)

SJR: 4.039
SNIP: 2.152
CiteScore: 16.2
Rank within the category: Biochemistry, Genetics and Molecular Biology - Molecular Medicine
Quartile: Q1
CiteScore percentile: 94%
CiteScore rank: 9 out of 167

Green Open Access

You Share, We Take Care!

Dutch copyright law (art. 25fa Auteurswet) allows you to deposit the publishers’ version (PDF) of short academic work in the university repository six months after the first (online) publication. The VU University Library can now support VU researchers who want to make their publications accessible in the VU Research Portal. If you have an employment contract with VU the library can automatically deposit published PDF-versions (Version of Record) of your academic publications on your behalf in the VU Research Portal.
Interested ? Read all about participation here

Sherpa/Romeo info
Official publisher policy

Sherpa Romeo information is accurate to the best of our knowledge but should not be relied upon for legal advice. (Last modified on: {{item.system_metadata.date_modified}})
For most accurate information, visit the Journal Home Page

Open Access pathways permitted by this journal's policy are listed below by article version.
Click on a pathway for a more detailed view.

  • Prerequisite: {{phrase.phrase}}.
  • Prerequisite for funders: , {{name.name}}.
  • No additional fee for OA publishing via this route.
  • There is an additional fee for OA publishing via this route.
  • There is a {{permission.embargo.amount}} {{permission.embargo.units}} embargo period for OA publishing via this route.
  • There is no embargo period for OA publishing via this route.
  • Copyright is owned by {{permission.copyright_owner}} when publishing via this route.
  • License: {{phrase.phrase}} {{license.version}}
  • Publisher deposit: {{name.name}}
  • Note: {{note}}
Can be published on:
  • {{ location.phrase }} in this list: , {{repo}}.
Conditions:
  • {{condition}}.
  • Prerequisite: {{phrase.phrase}}.
  • Prerequisite for funders: , {{name.name}}.
  • No additional fee for OA publishing via this route.
  • There is an additional fee for OA publishing via this route.
  • There is a {{permission.embargo.amount}} {{permission.embargo.units}} embargo period for OA publishing via this route.
  • There is no embargo period for OA publishing via this route.
  • Copyright is owned by {{permission.copyright_owner}} when publishing via this route.
  • License: {{phrase.phrase}} {{license.version}}
  • Publisher deposit: {{name.name}}
  • Note: {{note}}
Can be published on:
  • {{ location.phrase }} in this list: , {{repo}}.
Conditions:
  • {{condition}}.
  • Prerequisite: {{phrase.phrase}}.
  • Prerequisite for funders: , {{name.name}}.
  • No additional fee for OA publishing via this route.
  • There is an additional fee for OA publishing via this route.
  • There is a {{permission.embargo.amount}} {{permission.embargo.units}} embargo period for OA publishing via this route.
  • There is no embargo period for OA publishing via this route.
  • Copyright is owned by {{permission.copyright_owner}} when publishing via this route.
  • License: {{phrase.phrase}} {{license.version}}
  • Publisher deposit: {{name.name}}
  • Note: {{note}}
Can be published on:
  • {{ location.phrase }} in this list: , {{repo}}.
Conditions:
  • {{condition}}.

Recent Articles In: {{toc.journal.substring(17,toc.journal.length)}}